TY  - JOUR

T1  - Pooled analysis of phase II trials evaluating weekly or conventional cisplatin as first-line therapy for advanced urothelial carcinoma (UC).

JO  - Journal of Clinical Oncology

UR  - https://doi.org/10.1200/jco.2012.30.5_suppl.308

PY  - 2012/02/10

AU  - Agarwal N

AU  - Boucher KM

AU  - Maughan B

AU  - Hussain SA

AU  - Kaufman DS

AU  - Lorusso V

AU  - Moore MJ

AU  - Galsky MD

AU  - Sonpavde G

ED  - 

DO  - DOI: 10.1200/jco.2012.30.5_suppl.308

PB  - American Society of Clinical Oncology (ASCO)

VL  - 30

IS  - 5_suppl

SP  - 308

EP  - 308

Y2  - 2025/12/05

ER  -